Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9247 |
High Similarity |
NPD2801 |
Approved |
0.8816 |
High Similarity |
NPD5494 |
Approved |
0.88 |
High Similarity |
NPD3817 |
Phase 2 |
0.8667 |
High Similarity |
NPD1934 |
Approved |
0.863 |
High Similarity |
NPD1511 |
Approved |
0.8553 |
High Similarity |
NPD5402 |
Approved |
0.8531 |
High Similarity |
NPD2796 |
Approved |
0.8514 |
High Similarity |
NPD1512 |
Approved |
0.8497 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8487 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8322 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8252 |
Intermediate Similarity |
NPD1933 |
Approved |
0.825 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8176 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8133 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8125 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8092 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8079 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8038 |
Intermediate Similarity |
NPD919 |
Approved |
0.8037 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7959 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7898 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7793 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD920 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7682 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7639 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7632 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7625 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD943 |
Approved |
0.7562 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1613 |
Approved |
0.745 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7448 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7448 |
Intermediate Similarity |
NPD3267 |
Approved |
0.741 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7349 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6099 |
Approved |
0.732 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7317 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3268 |
Approved |
0.731 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5353 |
Approved |
0.729 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD37 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7273 |
Intermediate Similarity |
NPD17 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7256 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7256 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD411 |
Approved |
0.72 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7055 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7052 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8312 |
Approved |
0.702 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7 |
Intermediate Similarity |
NPD9494 |
Approved |
0.6988 |
Remote Similarity |
NPD4288 |
Approved |
0.6987 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6981 |
Remote Similarity |
NPD6190 |
Approved |
0.6981 |
Remote Similarity |
NPD2309 |
Approved |
0.698 |
Remote Similarity |
NPD1470 |
Approved |
0.6974 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6973 |
Remote Similarity |
NPD5006 |
Approved |
0.6973 |
Remote Similarity |
NPD5005 |
Approved |
0.6971 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6966 |
Remote Similarity |
NPD5585 |
Approved |
0.6962 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD4749 |
Approved |
0.6957 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6943 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6943 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD1201 |
Approved |
0.6913 |
Remote Similarity |
NPD1876 |
Approved |
0.691 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6894 |
Remote Similarity |
NPD7390 |
Discontinued |
0.689 |
Remote Similarity |
NPD2649 |
Approved |
0.689 |
Remote Similarity |
NPD2651 |
Approved |
0.689 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD2163 |
Approved |
0.6879 |
Remote Similarity |
NPD7228 |
Approved |
0.6875 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD9493 |
Approved |
0.6854 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6852
|
Remote Similarity |
NPD3146 |
Approved |